Explore how AI-based lung image analysis can help you innovate faster in precision medicine!
Precision Medicine is already happening, and Artificial Intelligence opens whole new possibilities for in-depth exploration and quantification of anatomical lung structures, disease-related pathologies, treatment effect and mechanism of action.
With more than 20 years of research background and a proven track record in powering innovations in pharmaceutical drug development and interventional medicine, we understand how to use AI in lung image analysis to its best potential.
Our advanced analysis deliver comprehensive assessment of common and rare pulmonary diseases, with consistently robust and reproducible results.
Join the demo presentations and meet Thirona experts at our exhibition booth
Monday, 9 September, 13:00 pm
Accelerating speed and precision of respiratory clinical trials with Artificial Intelligence-based lung imaging (in collaboration with Voiant Clinical)
Tuesday, 10 September, 13:00 pm
Quantitative assessment of bronchial abnormalities with Artificial Intelligence for emerging therapies in treatment of bronchiectasis
Jean-Paul Charbonnier, PhD
Chief Innovation Officer
Prof. Harm Tiddens, PhD
Chief Medical Officer
Rita Priori, PhD
Chief Technology Officer
Sanaz Berahmani, PhD
Business Development Manager
Leticia Gallardo, PhD
Deep Learning Lead
Abstract presentations of clinical validation studies with Thirona's LungQ™ analysis:
Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
